Osteogenesis Imperfecta
Musculoskeletal·MeSH: Osteogenesis Imperfecta
Prevalence
0.5 / 100K
8 drugs in development·5 companies·10 clinical trials
Drug Pipeline by Phase
Phase 3(5)
Phase 2(1)
Phase 1(1)
| Drug | Company |
|---|---|
| sar439459 | Sanofi (SNY) |
Preclinical(1)
| Drug | Company |
|---|---|
| nc605 | NextCure, Inc. (NXTC) |
Compare drugs
Frequently asked questions
How many drugs are in development for Osteogenesis Imperfecta?
BioSniper tracks 8 drugs in development for Osteogenesis Imperfecta across 5 companies.
How many clinical trials target Osteogenesis Imperfecta?
There are 10 clinical trials targeting Osteogenesis Imperfecta tracked by BioSniper.
What is the prevalence of Osteogenesis Imperfecta?
The estimated prevalence of Osteogenesis Imperfecta is approximately 0.5 per 100,000 population.
Deep-dive into Osteogenesis Imperfecta
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis